R, A., VD, B., T, J., E, S., A, B., D, L., . . . B, M. (2024). Intramyocardial immunomodulation with human CD16+ monocytes to treat myocardial infarction in pig: A blind randomized preclinical trial. Frontiers in cardiovascular medicine, 11, 1427023. https://doi.org/10.3389/fcvm.2024.1427023
Chicago Style (17th ed.) CitationR, Ascione, et al. "Intramyocardial Immunomodulation with Human CD16+ Monocytes to Treat Myocardial Infarction in Pig: A Blind Randomized Preclinical Trial." Frontiers in Cardiovascular Medicine 11 (2024): 1427023. https://doi.org/10.3389/fcvm.2024.1427023.
MLA (9th ed.) CitationR, Ascione, et al. "Intramyocardial Immunomodulation with Human CD16+ Monocytes to Treat Myocardial Infarction in Pig: A Blind Randomized Preclinical Trial." Frontiers in Cardiovascular Medicine, vol. 11, 2024, p. 1427023, https://doi.org/10.3389/fcvm.2024.1427023.